Cargando…
Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and Hedyotis diffusa Willd extract in vitro and in vivo
Arsenic trioxide (ATO) is clinically used to treat acute promyelocytic leukemia (APL); however, the therapeutic dose of ATO may prompt critical cardiac side effects. Combination therapy may be used to improve the therapeutic efficiency. To evaluate this possibility, the present study determined the...
Autores principales: | Kuo, Yu-Jui, Liu, Yan-Jin, Way, Tzong-Der, Chiang, Su-Yin, Lin, Jaung-Geng, Chung, Jing-Gung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450767/ https://www.ncbi.nlm.nih.gov/pubmed/28587418 http://dx.doi.org/10.3892/etm.2017.4392 |
Ejemplares similares
-
The Antitumor Constituents from Hedyotis Diffusa Willd
por: Wang, Changfu, et al.
Publicado: (2017) -
Exploring the mechanism of action of Hedyotis diffusa Willd on acne using network analysis
por: Seo, Gwangyeel, et al.
Publicado: (2023) -
The Hedyotis diffusa Willd. (Rubiaceae): A Review on Phytochemistry, Pharmacology, Quality Control and Pharmacokinetics
por: Chen, Rui, et al.
Publicado: (2016) -
Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts
por: Wu, Zihong, et al.
Publicado: (2022) -
Chemical Profiles and Protective Effect of Hedyotis diffusa Willd in Lipopolysaccharide-Induced Renal Inflammation Mice
por: Ye, Jian-Hong, et al.
Publicado: (2015)